To achieve success in this market, device manufacturers should consider working with providers to help contain costs and enhance outcomes.
No longer just “the big company advantage,” Arlen Ward discusses how CM&S is an accepted and viable device industry path to market for large and small medical device makers alike.
All industries under the healthcare umbrella should embrace each other’s capabilities because no single category of player can master it and bring to consumers all that we need and demand, says Stephen Bernstein of McDermott Will & Emery.
With everything to gain, telehealth may lead to a new standard in health/wellness treatment while at the same time unifying the entire healthcare ecosystem.
In a Q&A with Zipnosis, Catherine Murphy explains the uptick in telehealth visits and how it is changing the continuum of care.
Augmented reality and extended reality will play a front-and-center role in patient care.
Personalized medicine is the future of healthcare, and artificial intelligence will play a big role.
The settlement is one of a few that the company has made within the past several months.
Agency sanctions include a monetary penalty and revocation of the lab’s CLIA certificate.
Should your IDE device be reimbursed? FDA’s latest draft guidance will help CMS make the decision.